Skip to main content
Figure 1 | Lipids in Health and Disease

Figure 1

From: Atorvastatin 10 mg plus ezetimibe versus titration to atorvastatin 40 mg: attainment of European and Canadian guideline lipid targets in high-risk subjects ≥65 years

Figure 1

Proportion of subjects achieving targets defined by Canadian guidelines*. Error bars = standard error. *Canadian Cardiovascular Society/Canadian Dyslipidemia guidelines (2012)[4]. † Triple combination includes LDL-C ≤2.0 mmol/L, non-HDL-C ≤2.6 mmol/L, and Apo B ≤0.8 g/L. A, atorvastatin (10, 20 or 40 mg); Apo, apolipoprotein; AVD, atherosclerotic vascular disease; E, ezetimibe 10 mg; LDL-C, low-density lipoprotein cholesterol; non-HDL-C, non-high-density lipoprotein cholesterol.

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X